Propranolol or atenolol for the management of infantile hemangioma: Implications for long-term health

Hermans, Mireille M; Pasmans, Suzanne G M A; de Laat, Peter C J; Slieker, Martijn G; Mendels, Elodie J; de Graaf, Marlies; Langeveld, Hester R; Schappin, Renske; Rietman, André B; Breugem, Corstiaan C; Breur, Johannes M P J; de Wildt, Saskia N; Raphael, Martine F

doi:https://doi.org/10.1016/j.jdin.2023.02.001

Propranolol or atenolol for the management of infantile hemangioma: Implications for long-term health

DSpace/Manakin Repository

Propranolol or atenolol for the management of infantile hemangioma: Implications for long-term health

Hermans, Mireille M; Pasmans, Suzanne G M A; de Laat, Peter C J; Slieker, Martijn G; Mendels, Elodie J; de Graaf, Marlies; Langeveld, Hester R; Schappin, Renske; Rietman, André B; Breugem, Corstiaan C; Breur, Johannes M P J; de Wildt, Saskia N; Raphael, Martine F

(2023) JAAD international, volume 11, pp. 137 - 139

(Letter)

Download/Full Text

Open Access version via Utrecht University Repository

Publisher version

Version on publisher website for UU-students and staff

Version on publisher website

Keywords: adrenergic beta-antagonists, blood pressure, capillary hemangioma, child, growth and development, infant, long-term adverse effects, vascular malformations, vascular tissue neoplasms, Dermatology

DOI: https://doi.org/10.1016/j.jdin.2023.02.001

ISSN: 2666-3287

Publisher: Elsevier

Note: Funding Information: Funding sources: This investigator-initiated study was carried out with an unrestricted grant provided by Pierre Fabre Dermatologie.

(Peer reviewed)